AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLARITY PHARMACEUTICALS LTD

1.845

-0.115-5.87%

Volume:2.84M

Turnover:5.36M

Market Cap:686.40M

PE:-6.33

High:1.957

Open:1.950

Low:1.835

Close:1.960

52wk High:5.870

52wk Low:1.800

Shares:372.03M

Float Shares:274.26M

Volume Ratio:1.23

T/O Rate:1.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.291

EPS(LYR):-0.291

ROE:-77.54%

ROA:-45.12%

PB:3.69

PE(LYR):-6.33

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Clarity Pharmaceuticals Hits Recruitment Target for Main Group of Cancer Treatment Trial's Cohort Expansion

MT Newswires Live

ASX Penny Stocks To Watch In October 2026

Simply Wall St.

Clarity Pharmaceuticals Fiscal 2026 Loss Widens, Revenue Up

MT Newswires Live

Clarity Pharmaceuticals - FY Loss Attributable A$107.2 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hkg.itiger.com/stock/CU6.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CU6.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CU6.AU\",,,,,undefined,":{"symbol":"CU6.AU","market":"AU","secType":"STK","nameCN":"CLARITY PHARMACEUTICALS LTD","latestPrice":1.845,"timestamp":1791522720000,"preClose":1.96,"halted":0,"volume":2843745,"delay":0,"changeRate":-0.0586734693877551,"nameEN":"CLARITY PHARMACEUTICALS LTD","floatShares":274264090,"shares":372030071,"eps":-0.291397,"marketStatus":"Market Closed","change":-0.115,"latestTime":"10-09 16:12:00 AEDT","open":1.95,"high":1.957,"low":1.835,"amount":5362464,"amplitude":0.062245,"askPrice":1.87,"askSize":11031,"bidPrice":1.83,"bidSize":6092,"shortable":3,"etf":0,"ttmEps":-0.291397,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791759600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":1.96,"openAndCloseTimeList":[[1791500400000,1791522000000]],"volumeRatio":1.2309574071962381,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CU6.AU","preClose":1.96,"auctionPrice":1.845,"auctionVolume":161037,"auction":3,"marketStatus":"盘后竞价","timestamp":1791522607950}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CU6.AU\",,,,,undefined,":{"symbol":"CU6.AU","floatShares":274264090,"roa":"-45.12%","roe":"-77.54%","lyrEps":-0.291397,"volumeRatio":1.2309574071962381,"shares":372030071,"dividePrice":0,"high":1.957,"amplitude":0.062245,"preClose":1.96,"low":1.835,"week52Low":1.8,"pbRate":"3.69","psRate":"65.21","week52High":5.87,"institutionHeld":0,"latestPrice":1.845,"committee":-0.288442,"eps":-0.291397,"divideRate":0,"volume":2843745,"delay":0,"ttmEps":-0.291397,"open":1.95,"prevYearClose":3.38,"prevWeekClose":2.1,"prevMonthClose":2.1,"prevQuarterClose":2.1,"fiveDayClose":2.1,"twentyDayClose":2.21,"sixtyDayClose":2.32,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CU6.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CU6.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CU6.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673244046","title":"Clarity Pharmaceuticals Hits Recruitment Target for Main Group of Cancer Treatment Trial's Cohort Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2673244046","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673244046?lang=en_us&edition=fundamental","pubTime":"2026-10-08 08:17","pubTimestamp":1791418676,"startTime":"0","endTime":"0","summary":"Clarity Pharmaceuticals (ASX:CU6) achieved its recruitment target for the main group of the cohort expansion in a phase 1/2a trial that is evaluating a potential prostate cancer treatment, according t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081514","title":"ASX Penny Stocks To Watch In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081514","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081514?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:02","pubTimestamp":1791226943,"startTime":"0","endTime":"0","summary":"As the Australian market prepares for a potentially positive start to the week, investor sentiment remains cautious due to fluctuating bond yields and geopolitical factors. In this climate, penny stocks—often representing smaller or newer companies—continue to offer unique growth opportunities despite being considered a niche investment area. When these stocks are supported by solid financial health, they can provide attractive prospects for investors seeking under-the-radar companies with...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cu6/clarity-pharmaceuticals-shares/news/asx-penny-stocks-to-watch-in-october-2026-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cu6/clarity-pharmaceuticals-shares/news/asx-penny-stocks-to-watch-in-october-2026-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QAL.AU","CLX.AU","BK7058","BK7062","BK7121","CU6.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662225507","title":"Clarity Pharmaceuticals Fiscal 2026 Loss Widens, Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2662225507","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662225507?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:14","pubTimestamp":1787800481,"startTime":"0","endTime":"0","summary":"Clarity Pharmaceuticals (ASX:CU6) logged a AU$0.291 loss per share for fiscal 2026, compared with a loss of AU$0.201 a year ago, a Thursday filing showed.For the 12 months ended June 30, revenue from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CU6.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662724657","title":"Clarity Pharmaceuticals - FY Loss Attributable A$107.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662724657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662724657?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:32","pubTimestamp":1787797973,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE8FSRM4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CU6.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CU6.AU\",params:#limit:6,delay:true,,,undefined,":[]}}